Study on Ultrasound Screening and Combined Treatments for Patients With Coronary and Head and Neck Artery Narrowing

What this Trial Is About

This study focuses on patients with coronary artery disease CAD who are undergoing or scheduled for percutaneous coronary intervention PCI. It aims to understand how common and significant head and neck arterial narrowing stenosis is in these patients. Researchers will explore how different combined treatment approaches affect patient health, using real-world data to improve care for those with both heart and brain blood vessel diseases. The study observes three patient groups those receiving both PCI and carotid artery treatment, those who have PCI with no or untreated carotid stenosis, and those managed with observation only without PCI or carotid intervention. Doppler ultrasound is used as the main screening tool to assess artery narrowing. Patients are followed under their usual care without additional experimental treatments. Participants will have their artery conditions checked at baseline, with health outcomes tracked over time through measures like the modified Rankin Scale mRS and rates of cardiovascular and cerebrovascular events. These assessments occur shortly after treatment and continue for up to a year to monitor both short- and long-term complications. The total duration depends on the follow-up period after initial hospitalization and treatment.

A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis